In recent trading session, Aptose Biosciences Inc (NASDAQ:APTO) saw 1.21 million shares changing hands at last check today with its beta currently measuring 0.88. Company’s
Aptose Biosciences Inc (NASDAQ:APTO) has a beta value of 0.87 and has seen 1.96 million shares traded in the last trading session. The APTO stock
In the last trading session, 1.55 million shares of the Aptose Biosciences Inc (NASDAQ:APTO) were traded, and its beta was 0.88. Most recently the company’s
In the last trading session, 2.32 million shares of the Aptose Biosciences Inc (NASDAQ:APTO) were traded, and its beta was 0.91. Most recently the company’s
Aptose Biosciences Inc (NASDAQ:APTO)’s traded shares stood at 3.71 million during the last session, with the company’s beta value hitting 0.88. At the close of
In the last trading session, 8.08 million Aptose Biosciences Inc (NASDAQ:APTO) shares changed hands as the company’s beta touched 0.83. With the company’s per share
In last trading session, Aptose Biosciences Inc (NASDAQ:APTO) saw 28.71 million shares changing hands with its beta currently measuring 0.92. Company’s recent per share price
During the last session, Aptose Biosciences Inc (NASDAQ:APTO)’s traded shares were 1.18 million, with the beta value of the company hitting 0.94. At the end
During the recent session, Aptose Biosciences Inc (NASDAQ:APTO)’s traded shares were 0.86 million, with the beta value of the company hitting 0.94. At the last
In the last trading session, 1.12 million shares of the Aptose Biosciences Inc (NASDAQ:APTO) were traded, and its beta was 0.94. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
